CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | Ruddy Marcella K. Chief Medical Officer | Grant or award | +32,065 | 32,065 | ||
| 2024-06-20 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +43,946 | 43,946 | ||
| 2024-06-20 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +18,704 | 18,704 | ||
| 2024-06-20 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +81,700 | 81,700 | ||
| 2024-06-20 | McNamara Peter Chief Scientific Officer | Grant or award | +10,688 | 10,688 | ||
| 2024-06-20 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +37,959 | 37,959 | ||
| 2024-06-20 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,065 | 32,065 | ||
| 2024-06-20 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +18,704 | 18,704 | ||
| 2024-06-20 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +77,000 | 77,000 | ||
| 2024-06-20 | Lochner Daniel Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +118,000 | 118,000 | ||
| 2024-06-20 | Cortis Christian Chief Operating Officer | Grant or award | +126,368 | 126,368 | ||
| 2024-06-20 | Cortis Christian Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +56,061 | 56,061 | ||
| 2024-06-20 | Cortis Christian Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +18,704 | 18,704 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award | +166,580 | 166,580 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award | +124,530 | 124,530 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +33,923 | 33,923 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +23,380 | 23,380 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +289,600 | 289,600 | ||
| 2024-05-14 | Leonard Braden Michael 10% owner | Purchase | +296,882 | $1.30 | $386K | 4,768,262 |
| 2024-05-13 | Leonard Braden Michael 10% owner | Purchase | +253,700 | $1.24 | $313K | 4,255,327 |
Page 8 of 10 · 188 trades